Skip to main content
. 2020 Apr 28;21(9):3099. doi: 10.3390/ijms21093099
Mpro Main protease
SARS Severe acute respiratory syndrome
COVID-19 Coronavirus disease 2019
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
CoVs Coronaviruses
HCoV-NL63 Human coronavirus NL63
HCoV-229E Human coronavirus 229E
HCoV-OC43 Human coronavirus OC43
HCoV-HKU1 Human coronavirus HKU1
SARS-CoV Severe acute respiratory syndrome coronavirus
MERS-CoV Middle East respiratory syndrome coronavirus
ORFs Open reading frames
3CLpro Chymotrypsin-like cysteine protease
S Spike surface glycoprotein
E Small envelope protein
M Matrix protein
N Nucleocapsid protein
N3(PRD_002214) N-[(5 methylisoxazol-3-yl)carbonyl] alanyl-L-valyl-N~1-((1R,2Z)-4-(benzyloxy)-4-oxo-1-{[(3R)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-L-leucinamide
cMD Classical molecular dynamics simulations
MixMD Mixed-solvent molecular dynamics simulations
PDB Protein Data Bank
MAV Maximal accessible volume
ACN Acetonitrile
BNZ Benzene
DMSO Dimethylsulfoxide
MEO Methanol
PHN Phenol
URE Urea
CMA Correlated mutation analysis
FDA Food and Drug Administration